LSBCF (LakeShore Biopharma Co) Change In Receivables: $-2.01 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Change In Receivables?

LakeShore Biopharma Co LSBCF Change In Receivables is $-2.01 Mil as of Mar. 2025.

LakeShore Biopharma Co's change in receivables for the quarter that ended in Mar. 2025 was $0.00 Mil. It means LakeShore Biopharma Co's Accounts Receivable stayed the same from Sep. 2024 to Mar. 2025 .

LakeShore Biopharma Co's change in receivables for the fiscal year that ended in Mar. 2025 was $-8.23 Mil. It means LakeShore Biopharma Co's Accounts Receivable increased by $8.23 Mil from Mar. 2024 to Mar. 2025 .

LakeShore Biopharma Co's Accounts Receivable for the quarter that ended in Mar. 2025 was $69.10 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. LakeShore Biopharma Co's Days Sales Outstanding for the six months ended in Mar. 2025 was 376.18.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. LakeShore Biopharma Co's liquidation value for the six months ended in Mar. 2025 was $-48.33 Mil.

LakeShore Biopharma Co  (OTCPK:LSBCF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

LakeShore Biopharma Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=69.099/33.523*91
=376.18

2. In Ben Graham's calculation of liquidation value, LakeShore Biopharma Co's accounts receivable are only considered to be worth 75% of book value:

LakeShore Biopharma Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=3.874-119.723+0.75 * 69.099+0.5 * 31.395
=-48.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Change In Receivables Related Terms

LakeShore Biopharma Co Change In Receivables Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Change In Receivables Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Change In Receivables
-34.38 -10.88 -23.98 1.93 -8.23

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only 0.15 3.88 -2.01 0.00 0.00

LakeShore Biopharma Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-2.01 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Change In Receivables of $-2.01 Mil as of Mar. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Change In Receivables too high?
LakeShore Biopharma Co's current Change In Receivables is $-2.01 Mil.
How does LakeShore Biopharma Co's Change In Receivables compare to ACUT and PPCB?
LakeShore Biopharma Co's Change In Receivables of $-2.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Change In Receivables is $-2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Change In Receivables of $-2.01 Mil. The current Change In Receivables is $-2.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Change In Receivables is $-2.01 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.